Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000875320-25-000220
Filing Date
2025-08-07
Accepted
2025-08-07 16:23:31
Documents
1
Period of Report
2025-08-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1754598207.html 4  
1 FORM 4 wk-form4_1754598207.xml 4 5181
  Complete submission text file 0000875320-25-000220.txt   6607
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Issuer) CIK: 0000875320 (see all company filings)

EIN.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VERTEX PHARMACEUTICALS, INC. 50 NORTHERN AVENUE BOSTON MA 02210
Business Address
Kewalramani Reshma (Reporting) CIK: 0001735944 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19319 | Film No.: 251194457